查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587551

诊断酵素市场规模、份额、趋势分析报告：2025-2030 年按类型、应用、产品、最终用途、地区和细分市场进行的预测

Diagnostic Enzymes Market Size, Share & Trends Analysis Report By Type (Taq Polymerase, MMLV RT, HIV RT), By Application (Diabetes, Oncology, Cardiology), By Product, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

诊断酵素市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计2030年全球诊断酶市场规模将达到77.1亿美元，2025年至2030年复合年增长率为7.1%。

诊断酶市场的成长归因于对在病理学中广泛应用的诊断酶的需求不断增加。此外，病毒感染诊断技术的进步预计将推动市场成长。

由于酶活性提供的高灵敏度和准确性，诊断酶被广泛采用。酶活性可以比临床症状或其他诊断指标更早检测到。生物感测器是医疗诊断、病原体检测和监测的热门工具。生物感测器因其准确性、灵敏度、选择性和可常规使用的快速检测策略而受到欢迎。血清酵素水平的诊断已被用作细胞损伤的指标，导致细胞间成分释放到血流中。

呼吸道病毒感染疾病是最常见的人类疾病之一，由 COVID-19 等新出现的病毒爆发引起的感染疾病对公共卫生构成威胁。因此，检测病毒病原体对于预防此类流行病的发生和防止不必要的抗生素使用至关重要。因此，主要参与者正在采用新的诊断策略。 LightMix（罗氏分子诊断公司，瑞士）、AccuPower（Bioneer，韩国）、PowerChek（Kogene Biotech，韩国）、Anyplex（Seegene，韩国）、UltraFast 试剂盒（Nanobiosys，韩国）、DiaPlexQ（SolGent，韩国）它是市出售的RNA 检测RT-PCR 试剂套件的一部分，灵敏度高达 99.03%。

诊断酶测试数量的增加导致更多关于其性能的出版物以及建议和指南的增加。此外，报销途径缺乏明确的指导方针和系统的卫生技术评估（HTA）。多种因素影响付款人对诊断酶测试的决定，包括 FDA 批准、医生认可和临床指南、竞争对手覆盖政策、成本/效益分析、HTA 结果、雇主和支持团体的要求。

此外，该市场的主要企业都致力于扩大和推出可用于广泛应用的产品。例如，2022年3月，Meridian Biosciences推出了两种可用于非侵入性液态切片的预混液。与传统的精製核酸 qPCR 相比，此类突破性技术的推出可实现卓越的分析性能水准。

诊断酵素市场报告亮点

  • 葡萄糖氧化酵素/去氢酶细分市场在 2024 年占据最大收益占有率，为 9.3%。葡萄糖氧化酵素（GOx）的需求量很大，主要是因为它在血糖监测中的重要作用及其在各个生物医学领域的日益广泛的应用。
  • 乳酸去氢酶（LDH）领域预计将在预测期内显着增长，这主要是由于越来越多地采用分子设备进行糖尿病管理。
  • 感染疾病领域占最大市场占有率，2024年为36.0%。 PCR技术的广泛应用使感染疾病的早期识别和治疗取得了重大进展。
  • 预计肿瘤学领域在预测期内将以 8.8% 的复合年增长率成长。
  • 2024年，临床酵素业务占最大收益占有率，达65.3%。
  • 2024年，临床实验室领域占最大市场占有率，达48.2%。该细分市场的成长受到多种因素的推动。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章诊断酵素市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 诊断酵素市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章诊断酵素市场：类型估计与趋势分析

  • 细分仪表板
  • 诊断酵素市场：类型变异分析
  • 按类型分類的诊断酶市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • Taq聚合酵素
  • MMLV RT
  • HIV RT
  • 热启动塔克波尔
  • UNG
  • 核糖核酸酶抑制剂
  • Bst聚合酵素（LAMP酶）
  • PCR预混液
  • 冻干聚合酵素
  • T7 RNA聚合酵素
  • Cas9酶
  • 酸性磷酸酶
  • 丙氨酸胺基转移酶
  • 碱性磷酸酶
  • 淀粉酶
  • 血管收缩素转化酵素
  • 天门冬胺酸胺基转移酶
  • 胆碱酯酶
  • 肌酸酐激酶
  • γ谷氨酰转移酶
  • 乳酸脱氢酵素
  • 列宁
  • 葡萄糖氧化酵素/葡萄糖去氢酵素
  • 尿素酶
  • 乳酸氧化酶
  • 过氧化氢辣根
  • 麸胺酸氧化酶
  • 其他的

第五章诊断酵素市场：应用估算与趋势分析

  • 细分仪表板
  • 诊断酵素市场：应用变化分析
  • 诊断酵素市场应用前景
  • 2018-2030年市场规模、预测及趋势分析
  • 糖尿病
  • 肿瘤学
  • 心臟病学
  • 感染疾病
  • 肾臟病学
  • 自体免疫疾病
  • 其他的

第六章诊断酵素市场：产品估算与趋势分析

  • 细分仪表板
  • 诊断酵素市场：产品变异分析
  • 按产品分類的诊断酵素市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 分子酵素
  • 临床酵素

第七章诊断酵素市场：最终用途估计与趋势分析

  • 细分仪表板
  • 诊断酵素市场：最终用途变异分析
  • 按最终用途分類的诊断酵素市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 医院
  • 临床实验室
  • 其他的

第八章诊断酵素市场：区域估计和趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 市场参与企业分类
  • 主要市场参与企业的最新趋势和影响分析
  • 2024 年企业市场占有率分析
  • 主要企业简介
    • Takara Bio, Inc.
    • Promega Corporation
    • Enzo Biochem Inc
    • Merck KGaA
    • Thermo Fisher Scientific, Inc
    • Creative Enzymes
    • F. Hoffmann-La Roche Ltd.
    • Solis BioDyne
    • Ambliqon A/S.
    • Yashraj Biotechnology Ltd.
Product Code: GVR-4-68040-003-4

Diagnostic Enzymes Market Growth & Trends:

The global diagnostic enzymes market size is expected to reach USD 7.71 billion by 2030, registering a CAGR of 7.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growth of the diagnostic enzymes market is attributed to rising demand for the enzymes in diagnostics with wide applications in pathology. Moreover, advancements in diagnostic techniques for viral infection are anticipated to propel the market growth.

Diagnostic enzymes are widely adopted owing to the higher sensitivity and accuracy offered by enzyme activity. The enzyme activities can be earlier than clinical signs and other diagnostic indicators. Biosensors are becoming a popular potential tool for medical diagnostics, pathogen detection, and monitoring. Biosensors have gained popularity owing to the accuracy, sensitivity, selectivity, and rapid detection strategies that can be used routinely. Diagnosis of serum levels of the enzymes has been used as an indicator of the cellular damage that results in the release of the intercellular components into the bloodstream.

Viral infections of the respiratory tract are among the most common disorders in humans, and the ones caused due to the outbreak of emerging viruses, such as COVID-19, have posed a threat to public health. Therefore, detection of the viral pathogens is vital to stop the occurrence of such epidemics and prevent the unnecessary use of antibiotics. Therefore, novel diagnostic strategies have been adopted by the key players. LightMix (Roche Molecular Diagnostics, Switzerland), AccuPower (Bioneer, Korea), PowerChek (Kogene Biotech, Korea), Anyplex (Seegene, Korea), UltraFast kits (Nanobiosys, Korea), and DiaPlexQ (SolGent, Korea) are some of the commercially available RT-PCR kits for MERS-CoV RNA detection with sensitivities as high as 99.03%.

An increase in the number of diagnostic enzyme tests has led to a boost in recommendations and guidelines with a number of publications on their performance. Moreover, reimbursement pathways lack clear guidelines and systematic Health Technology Assessment (HTA). Various factors influencing payer decisions for diagnostic enzyme tests include FDA clearance, physician support & clinical guidelines, competitor coverage policies, cost/benefit analyses, results of HTAs, and employer or advocacy group demands.

Furthermore, key players operating in the market are focusing on expanding and launching products that can be used for a wide range of applications. For instance, in March 2022, Meridian Bioscience, Inc. launched two master mixes, which can be used in non-invasive liquid biopsy. The launch of such breakthrough technologies enables better analysis of the performance levels as compared to traditional qPCR from the purified nucleic acid.

Diagnostic Enzymes Market Report Highlights:

  • The glucose oxidase/dehydrogenase segment accounted for the largest revenue share of 9.3% in 2024. Glucose oxidase (GOx) is in high demand primarily due to its essential role in glucose monitoring and its increasing applications in various biomedical fields.
  • The lactate dehydrogenase (LDH) segment is anticipated to experience substantial growth throughout the forecast period, largely driven by the rising adoption of molecular devices for diabetes management.
  • The infectious diseases segment held the largest market share of 36.0% in 2024. The widespread application of PCR technology has significantly advanced the early identification and treatment of infectious diseases.
  • The oncology segment is expected to grow at a CAGR of 8.8% over the forecast period.
  • The clinical enzyme segment accounted for the largest revenue share of 65.3% in 2024, largely due to the increasing application of enzymes in clinical chemistry.
  • The clinical laboratories segment held the largest market share of 48.2% in 2024. The segment growth is driven by multiple factors.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Type
    • 1.2.3. Application
    • 1.2.4. End Use
    • 1.2.5. Regional Scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Diagnostic Enzymes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rise in the demand for enzymes in pathology
      • 3.2.1.2. Advancements in diagnostic testing of viral infection
      • 3.2.1.3. Increase in the demand for Point-of-Care testing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of enzyme-based diagnostic tests
      • 3.2.2.2. Regulatory & reimbursement hurdles for enzyme diagnostics
  • 3.3. Diagnostic Enzymes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Diagnostic Enzymes Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Diagnostic Enzymes Market: Type Movement Analysis
  • 4.3. Diagnostic Enzymes Market by Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Taq Polymerase
    • 4.5.1. Taq Polymerase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. MMLV RT
    • 4.6.1. MMLV RT Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. HIV RT
    • 4.7.1. HIV RT Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Hot Start Taq Pol
    • 4.8.1. Hot Start Taq Pol Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. UNG
    • 4.9.1. UNG Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.10. Rnase Inhibitors
    • 4.10.1. Rnase Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.11. Bst Polymerase (LAMP ENZYME)
    • 4.11.1. Bst Polymerase (LAMP ENZYME) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.12. PCR Master Mix
    • 4.12.1. PCR Master Mix Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.13. Lyophilized Polymerase
    • 4.13.1. Lyophilized Polymerase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.14. T7 Rna Polymerase
    • 4.14.1. T7 Rna Polymerase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.15. Cas9 Enzyme
    • 4.15.1. Cas9 Enzyme Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.16. Acid Phosphatase
    • 4.16.1. Acid Phosphatase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.17. Alanine Aminotransferase
    • 4.17.1. Alanine Aminotransferase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.18. Alkaline Phosphatase
    • 4.18.1. Alkaline Phosphatase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.19. Amylase
    • 4.19.1. Amylase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.20. Angiotensin Converting Enzyme
    • 4.20.1. Angiotensin Converting Enzyme Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.21. Aspartate Aminotransferase
    • 4.21.1. Aspartate Aminotransferase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.22. Cholinesterase
    • 4.22.1. Cholinesterase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.23. Creatinine Kinase
    • 4.23.1. Creatinine Kinase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.24. Gamma Glutamyl Transferase
    • 4.24.1. Gamma Glutamyl Transferase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.25. Lactate Dehydrogenase
    • 4.25.1. Lactate Dehydrogenase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.26. Renin
    • 4.26.1. Renin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.27. Glucose Oxidase/Glucose Dehydrogenase
    • 4.27.1. Glucose Oxidase/Glucose Dehydrogenase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.28. Urease
    • 4.28.1. Urease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.29. Lactate Oxidase
    • 4.29.1. Lactate Oxidase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.30. Horseradish Peroxide
    • 4.30.1. Horseradish Peroxide Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.31. Glutamate Oxidase
    • 4.31.1. Glutamate Oxidase Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.32. Others
    • 4.32.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Diagnostic Enzymes Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Diagnostic Enzymes Market: Application Movement Analysis
  • 5.3. Diagnostic Enzymes Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Diabetes
    • 5.5.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Oncology
    • 5.6.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Cardiology
    • 5.7.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Infectious Disease
    • 5.8.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Nephrology
    • 5.9.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Autoimmune Diseases
    • 5.10.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Diagnostic Enzymes Market: Product Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Diagnostic Enzymes Market: Product Movement Analysis
  • 6.3. Diagnostic Enzymes Market by Product Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Molecular Enzymes
    • 6.5.1. Molecular Enzymes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Clinical Enzymes
    • 6.6.1. Clinical Enzymes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Diagnostic Enzymes Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Diagnostic Enzymes Market: End Use Movement Analysis
  • 7.3. Diagnostic Enzymes Market by End Use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. Hospital
    • 7.5.1. Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Clinical Laboratories
    • 7.6.1. Clinical Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Diagnostic Enzymes Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Recent Developments & Impact Analysis by Key Market Participants
  • 9.3. Company Market Share Analysis, 2024
  • 9.4. Key Company Profiles
    • 9.4.1. Takara Bio, Inc.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Promega Corporation
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Enzo Biochem Inc
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Merck KGaA
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Thermo Fisher Scientific, Inc
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Creative Enzymes
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. F. Hoffmann-La Roche Ltd.
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Solis BioDyne
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Ambliqon A/S.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Yashraj Biotechnology Ltd.
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1. List of abbreviation
  • Table 2. North America Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 3. North America Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 4. North America Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 5. North America Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 6. North America Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 7. U.S. Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 8. U.S. Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 9. U.S. Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 10. U.S. Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 11. Canada Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 12. Canada Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 13. Canada Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 14. Canada Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 15. Mexico Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 16. Mexico Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 17. Mexico Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 18. Mexico Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 19. Europe Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 20. Europe Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 21. Europe Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 22. Europe Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 23. Europe Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 24. Germany Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 25. Germany Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 26. Germany Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 27. Germany Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 28. UK Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 29. UK Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 30. UK Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 31. UK Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 32. France Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 33. France Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 34. France Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 35. France Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 36. Italy Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 37. Italy Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 38. Italy Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 39. Italy Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 40. Spain Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 41. Spain Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 42. Spain Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 43. Spain Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 44. Denmark Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 45. Denmark Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 46. Denmark Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 47. Denmark Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 48. Sweden Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 49. Sweden Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 50. Sweden Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 51. Sweden Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 52. Norway Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 53. Norway Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 54. Norway Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 55. Norway Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 56. Asia Pacific Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 57. Asia Pacific Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 58. Asia Pacific Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 59. Asia Pacific Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 60. Asia Pacific Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 61. China Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 62. China Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 63. China Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 64. China Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 65. Japan Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 66. Japan Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 67. Japan Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 68. Japan Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 69. India Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 70. India Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 71. India Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 72. India Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 73. South Korea Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 74. South Korea Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 75. South Korea Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 76. South Korea Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 77. Australia Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 78. Australia Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 79. Australia Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 80. Australia Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 81. Thailand Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 82. Thailand Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 83. Thailand Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 84. Thailand Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 85. Latin America Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 86. Latin America Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 87. Latin America Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 88. Latin America Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 89. Latin America Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 90. Brazil Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 91. Brazil Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 92. Brazil Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 93. Brazil Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 94. Argentina Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 95. Argentina Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 96. Argentina Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 97. Argentina Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 98. MEA Diagnostic Enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 99. MEA Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 100. MEA Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 101. MEA Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 102. MEA Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 103. South Africa Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 104. South Africa Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 105. South Africa Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 106. South Africa Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 107. Saudi Arabia Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 108. Saudi Arabia Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 109. Saudi Arabia Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 110. Saudi Arabia Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 111. UAE Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 112. UAE Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 113. UAE Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 114. UAE Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 115. Kuwait Diagnostic Enzymes market, by type, 2018 - 2030 (USD Million)
  • Table 116. Kuwait Diagnostic Enzymes market, by application, 2018 - 2030 (USD Million)
  • Table 117. Kuwait Diagnostic Enzymes market, by product, 2018 - 2030 (USD Million)
  • Table 118. Kuwait Diagnostic Enzymes market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1. Market research process
  • Fig. 2. Data triangulation techniques
  • Fig. 3. Primary research pattern
  • Fig. 4. Primary interviews in North America
  • Fig. 5. Primary interviews in Europe
  • Fig. 6. Primary interviews in APAC
  • Fig. 7. Primary interviews in Latin America
  • Fig. 8. Primary interviews in MEA
  • Fig. 9. Market research approaches
  • Fig. 10. Value-chain-based sizing & forecasting
  • Fig. 11. QFD modeling for market share assessment
  • Fig. 12. Market formulation & validation
  • Fig. 13. Diagnostic Enzymes market: market outlook
  • Fig. 14. Diagnostic Enzymes competitive insights
  • Fig. 15. Parent market outlook
  • Fig. 16. Related/ancillary market outlook
  • Fig. 17. Diagnostic Enzymes market driver impact
  • Fig. 18. Diagnostic Enzymes market restraint impact
  • Fig. 19. Diagnostic Enzymes market: Type movement analysis
  • Fig. 20. Diagnostic Enzymes market: Type outlook and key takeaways
  • Fig. 21. Taq polymerase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22. MMLV-RT market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23. HIV RT market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24. Hot start Taq pol market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25. UNG market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26. RNase inhibitor market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27. Bst polymerase (LAMP enzyme) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28. PCR Master Mix market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29. Lyophilised Polymerase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30. T7 RNA polymerase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31. Cas9 enzyme market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32. Acid phosphatase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33. Alanine aminotransferase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34. Alkaline phosphatase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35. Amylase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36. Angiotensin converting enzyme market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37. Aspartate aminotransferase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38. Cholinesterase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39. Creatinine kinase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40. Gamma glutamyl transferase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41. Lactate dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42. Renin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43. Glucose oxidase/glucose dehydrogenase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44. Urease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45. Lactate oxidase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46. Horseradish peroxidase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47. Glutamate oxidase market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48. Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49. Diagnostic Enzymes market: Application movement analysis
  • Fig. 50. Diagnostic Enzymes market: Application outlook and key takeaways
  • Fig. 51. Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52. Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53. Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54. Infectious Diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55. Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56. Autoimmune Diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57. Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58. Diagnostic Enzymes market: Product movement analysis
  • Fig. 59. Diagnostic Enzymes market: Product outlook and key takeaways
  • Fig. 60. Molecular Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61. Clinical Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62. Diagnostic Enzymes market: End Use movement analysis
  • Fig. 63. Diagnostic Enzymes market: End Use outlook and key takeaways
  • Fig. 64. Hospital market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65. Clinical Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66. Other End Users market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67. Global Diagnostic Enzymes market: Regional movement analysis
  • Fig. 68. Global Diagnostic Enzymes market: Regional outlook and key takeaways
  • Fig. 69. Global Diagnostic Enzymes market share and leading players
  • Fig. 70. North America, by country
  • Fig. 71. North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72. U.S. key country dynamics
  • Fig. 73. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74. Canada key country dynamics
  • Fig. 75. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76. Mexico key country dynamics
  • Fig. 77. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78. Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79. UK key country dynamics
  • Fig. 80. UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81. Germany key country dynamics
  • Fig. 82. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83. France key country dynamics
  • Fig. 84. France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85. Italy key country dynamics
  • Fig. 86. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87. Spain key country dynamics
  • Fig. 88. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89. Denmark key country dynamics
  • Fig. 90. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91. Sweden key country dynamics
  • Fig. 92. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93. Norway key country dynamics
  • Fig. 94. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96. China key country dynamics
  • Fig. 97. China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98. Japan key country dynamics
  • Fig. 99. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100. India key country dynamics
  • Fig. 101. India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102. Thailand key country dynamics
  • Fig. 103. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104. South Korea key country dynamics
  • Fig. 105. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 106. Australia key country dynamics
  • Fig. 107. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 108. Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109. Brazil key country dynamics
  • Fig. 110. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 111. Argentina key country dynamics
  • Fig. 112. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 113. Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 114. South Africa key country dynamics
  • Fig. 115. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 116. Saudi Arabia key country dynamics
  • Fig. 117. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 118. UAE key country dynamics